Buy, Sell or Hold JAZZ Stock? Key Tips Ahead of Q1 Earnings

Investors will likely focus on the sales performance of Jazz Pharmaceuticals’ key neuroscience drugs, Xywav and Rylaze, when it reports Q1 results next week.